194 related articles for article (PubMed ID: 2833755)
41. Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
van Denderen J; van der Plas D; Meeuwsen T; Zegers N; Boersma W; Grosveld G; van Ewijk W
Blood; 1990 Jul; 76(1):136-41. PubMed ID: 2194587
[TBL] [Abstract][Full Text] [Related]
42. No correlation between site of breakpoint in the BCR gene and platelet counts in Philadelphia chromosome-positive CML.
Opalka B; Wandl UB; Kloke O; Beer U; Seeber S; Niederle N
Leuk Res; 1992 Sep; 16(9):937-9. PubMed ID: 1405723
[TBL] [Abstract][Full Text] [Related]
43. Studies of BCR rearrangements in Philadelphia-positive acute leukemia.
Hillion J; Flexor MA; Larsen CJ; Berger R
Cancer Genet Cytogenet; 1991 Feb; 51(2):259-67. PubMed ID: 1993310
[TBL] [Abstract][Full Text] [Related]
44. Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease.
Verhoef GE; Demuynck H; Stul MS; Cassiman JJ; Mecucci C; Van Den Berghe H; Boogaerts MA
Cancer Genet Cytogenet; 1990 Oct; 49(2):171-6. PubMed ID: 1976433
[TBL] [Abstract][Full Text] [Related]
45. Sequence-specific DNA-binding proteins within the Mbcr on the Ph1 chromosome.
Leibowitz D; Young K; Cox G
Genes Chromosomes Cancer; 1991 Jul; 3(4):308-12. PubMed ID: 1958595
[TBL] [Abstract][Full Text] [Related]
46. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.
McLaughlin J; Chianese E; Witte ON
Mol Cell Biol; 1989 May; 9(5):1866-74. PubMed ID: 2747638
[TBL] [Abstract][Full Text] [Related]
47. Molecular analysis of the translocation breakpoint in a Philadelphia-positive, bcr-negative ALL patient.
van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
Haematol Blood Transfus; 1989; 32():331-4. PubMed ID: 2625253
[No Abstract] [Full Text] [Related]
48. The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2.
Burnett RC; David JC; Harden AM; Le Beau MM; Rowley JD; Diaz MO
Genes Chromosomes Cancer; 1991 Nov; 3(6):461-7. PubMed ID: 1663780
[TBL] [Abstract][Full Text] [Related]
49. Occurrence of high-grade T-cell lymphoma in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: case report and review of the literature.
Djulbegović B; Hadley T; Yen F
Am J Hematol; 1991 Jan; 36(1):63-4. PubMed ID: 1984685
[TBL] [Abstract][Full Text] [Related]
50. The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia.
Inokuchi K; Futaki M; Yamada T; Tanabe Y; Dan K; Shinohara T; Kuriya S; Nomura T
Leuk Res; 1991; 15(11):1067-73. PubMed ID: 1961010
[TBL] [Abstract][Full Text] [Related]
51. The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukemia.
Jaubert J; Martiat P; Dowding C; Ifrah N; Goldman JM
Br J Haematol; 1990 Jan; 74(1):30-5. PubMed ID: 2310695
[TBL] [Abstract][Full Text] [Related]
52. Philadelphia-positive thrombocythemia with a complex translocation involving chromosomes 9, 15, and 22.
Palumbo AP; Boccadoro M; Battaglio S; Corradini P; Giovinazzo B; Avanzi G; Ponzio G
Cancer Genet Cytogenet; 1989 May; 39(1):77-80. PubMed ID: 2731151
[TBL] [Abstract][Full Text] [Related]
53. De novo Ph negative T-cell lymphoblastic leukaemia associated with bcr gene rearrangement.
Middleton PG; Davison EV; Reid MM; Proctor SJ
Leuk Res; 1990; 14(1):99-103. PubMed ID: 2304357
[TBL] [Abstract][Full Text] [Related]
54. bcr rearrangements in Philadelphia chromosome-positive acute lymphoblastic leukemia. A study of five Chinese patients in Taiwan.
Lin MT; Tien HF; Wang CH; Chen YC; Lin DT; Lin KH
Cancer Genet Cytogenet; 1990 Jul; 47(1):29-39. PubMed ID: 2357685
[TBL] [Abstract][Full Text] [Related]
55. Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.
Komorowski L; Fidyt K; Patkowska E; Firczuk M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806528
[TBL] [Abstract][Full Text] [Related]
56. bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.
Bartram CR
J Exp Med; 1985 Dec; 162(6):2175-9. PubMed ID: 2415665
[TBL] [Abstract][Full Text] [Related]
57. Ph chromosome in a patient with non-leukemic non-Hodgkin B-cell lymphoma.
Fujii H; Yashige H; Misawa S; Tanaka S; Urata Y; Matuyama F
Am J Hematol; 1990 Nov; 35(3):213-5. PubMed ID: 2220768
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.
Shah NP; Witte ON; Denny CT
Mol Cell Biol; 1991 Apr; 11(4):1854-60. PubMed ID: 1900918
[TBL] [Abstract][Full Text] [Related]
59. Do oncogenes determine clinical features in chronic myeloid leukaemia?
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Lancet; 1987 Jun; 1(8547):1402-5. PubMed ID: 2884497
[TBL] [Abstract][Full Text] [Related]
60. Complex translocation involving Ph chromosome in a patient with typical chronic myelogenous leukemia.
Calabrese G; Palka G; Westbrook CA; Sheer D
Cancer Genet Cytogenet; 1992 Oct; 63(1):52-5. PubMed ID: 1423227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
